NCT01899846View on ClinicalTrials.gov

Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Pregnancy
Interventions
DRUG

Hydroxyprogesterone caproate 250 mg/ml

Trial Locations (6)

27599

University of North Carolina at Chapel Hill Hospital, Chapel Hill

27710

Duke University, Durham

33461

Altus Research, Inc., Lake Worth

53715

The University of Wisconsin, Madison

60611

Northwestern University Department of Obstetrics and Gynecology, Chicago

83404

Rosemark WomenCare Specialists, Idaho Falls

Sponsors
All Listed Sponsors
lead

Lumara Health, Inc.

INDUSTRY